Community-acquired pneumonia (CAP) had remained one of the leading causes of infectious disease-related morbidity, hospitalization, and mortality worldwide. It was defined as an acute infection of the pulmonary parenchyma that developed outside hospital settings or was diagnosed within the initial period of hospital admission. The condition had affected individuals across all age groups, although elderly patients and those with underlying medical conditions experienced more severe disease and poorer clinical outcomes [1]. Despite considerable improvements in diagnostic facilities, antimicrobial therapy, and supportive care, CAP continued to represent a substantial clinical burden, particularly in developing countries where delayed healthcare access, antimicrobial resistance, and limited diagnostic resources frequently complicated disease management. Early identification of patients who were likely to respond favorably to treatment was therefore considered essential for improving clinical outcomes and reducing hospital-related complications.

The clinical presentation of CAP had varied considerably depending on the causative organism, severity of infection, host immune response, and presence of associated comorbidities [2]. Common presenting symptoms included fever, cough, sputum production, dyspnea, pleuritic chest pain, fatigue, and reduced appetite. Physical examination frequently revealed tachypnea, tachycardia, reduced oxygen saturation, and abnormal pulmonary auscultatory findings, including crackles and bronchial breath sounds. Laboratory investigations, particularly total leukocyte count, C-reactive protein, procalcitonin, and renal function parameters, had provided additional information regarding the inflammatory response and systemic involvement [3]. Certain clinical characteristics, including advanced age, diabetes mellitus, chronic obstructive pulmonary disease, cardiovascular disorders, renal impairment, and immunosuppression, had been associated with increased disease severity and delayed treatment response.

Radiological assessment had played an important role in establishing the diagnosis, determining disease extent, and evaluating pulmonary involvement among hospitalized patients with CAP. Chest radiography had traditionally been considered the initial imaging investigation because it provided evidence of pulmonary infiltrates, consolidation, pleural effusion, and multilobar involvement [4]. Different radiological patterns, including lobar consolidation, bronchopneumonia, and interstitial infiltrates, had been observed according to the underlying pathological process and causative microorganisms. The presence of bilateral infiltrates, multilobar consolidation, extensive pulmonary opacities, and pleural effusion had frequently indicated more extensive disease and potentially unfavorable clinical outcomes. Radiological findings had therefore complemented clinical assessment by providing valuable information regarding the anatomical distribution and severity of pulmonary infection [5].

Treatment response among patients hospitalized with CAP had depended on several interacting clinical, biochemical, microbiological, and radiological factors. Appropriate antimicrobial therapy, adequate oxygen supplementation, hydration, and supportive management had contributed to clinical improvement. A favorable response was generally reflected by resolution of fever, improvement in respiratory symptoms, stabilization of vital signs, improved oxygenation, and reduction in inflammatory markers [6]. Conversely, persistent fever, worsening respiratory distress, increasing oxygen requirements, hemodynamic instability, and progressive radiological abnormalities had suggested inadequate treatment response or disease progression. Delayed clinical improvement had also increased the likelihood of prolonged hospitalization, intensive care admission, mechanical ventilation, and mortality. Assessment of early treatment response was consequently important for identifying patients who required additional investigations, modification of antimicrobial therapy, or escalation of supportive care.

Several severity assessment tools, including the CURB-65 score and Pneumonia Severity Index, had been developed to estimate mortality risk and guide decisions regarding hospitalization and treatment intensity [7]. Although these scoring systems had improved clinical risk stratification, they had not completely addressed the combined predictive contribution of individual clinical characteristics and radiological abnormalities. Furthermore, differences in patient demographics, comorbid conditions, healthcare accessibility, and local patterns of antimicrobial resistance had influenced treatment outcomes across different populations. Hospital-based evidence from Pakistan had therefore remained important for understanding the factors associated with treatment response in patients with CAP [8].

A prospective observational assessment of clinical and radiological predictors had offered an opportunity to evaluate these factors systematically during hospitalization. Identification of reliable predictors could have supported early risk stratification, individualized treatment decisions, timely intervention, and improved utilization of hospital resources [9]. Therefore, the present study was designed to evaluate clinical and radiological predictors of treatment response among patients hospitalized with community-acquired pneumonia at Shaheed Mohtarma Benazir Bhutto Medical University Larkana. The study also aimed to identify patient characteristics, clinical manifestations, laboratory parameters, and radiological findings that were associated with favorable or unfavorable treatment outcomes [10].

Study Design and Patient Selection

This prospective observational study was conducted at the Department of Pulmonology and Medicine, Shaheed Mohtarma Benazir Bhutto Medical University Larkana, from November 2025 to April 2026. A total of 80 patients who were hospitalized with community-acquired pneumonia (CAP) were enrolled. The study was designed to evaluate clinical and radiological predictors associated with treatment response and to identify factors that influenced clinical recovery, hospital stay, and treatment outcomes. Patients were recruited through a consecutive sampling technique after fulfilling the predefined eligibility criteria.

Inclusion and Exclusion Criteria

Patients aged 18 years or older who were admitted with a clinical diagnosis of community-acquired pneumonia were included. The diagnosis was established on the basis of compatible clinical manifestations, including fever, cough, sputum production, dyspnea, chest discomfort, and abnormal respiratory examination findings, along with new radiological pulmonary infiltrates. Patients who required hospitalization for the management of pneumonia and had sufficient clinical and radiological information available were eligible for enrollment.

Patients with hospital-acquired pneumonia, ventilator-associated pneumonia, active pulmonary tuberculosis, known lung malignancy, or severe immunocompromised conditions were excluded. Patients with pre-existing interstitial lung disease, recent hospitalization associated with pneumonia, or incomplete medical records were also excluded to minimize potential confounding factors.

Clinical Assessment and Data Collection

Detailed clinical and demographic information was collected from all enrolled patients using a structured data collection proforma. The recorded variables included age, gender, smoking history, comorbidities, duration of symptoms, previous respiratory illnesses, and presenting clinical features. Particular attention was given to diabetes mellitus, hypertension, chronic obstructive pulmonary disease, ischemic heart disease, and chronic kidney disease.

At admission, vital parameters were documented, including temperature, heart rate, respiratory rate, blood pressure, and peripheral oxygen saturation (SpO₂). Clinical severity was assessed using the CURB-65 scoring system, which included confusion, blood urea nitrogen, respiratory rate, blood pressure, and age of 65 years or above. Laboratory investigations included complete blood count, serum urea, creatinine, C-reactive protein, and other relevant biochemical parameters. Arterial blood gas analysis was performed when clinically indicated.

Radiological Assessment

All patients underwent chest radiography at admission to evaluate the presence, distribution, and extent of pulmonary infiltrates. Radiological findings were documented according to the affected lung zones, laterality, and pattern of involvement. Findings included unilateral or bilateral consolidation, multilobar involvement, pleural effusion, and other associated abnormalities. Computed tomography of the chest was performed when clinically indicated to clarify uncertain radiographic findings or assess suspected complications. Radiological severity was categorized according to the extent of pulmonary involvement and the presence of bilateral or multilobar disease.

Assessment of Treatment Response

Treatment response was evaluated through serial clinical assessments during hospitalization. Patients were managed according to institutional protocols and standard recommendations for community-acquired pneumonia. Antibiotic selection was determined by the treating physicians according to clinical severity, suspected pathogens, and relevant investigation findings.

Treatment response was assessed using improvement in fever, respiratory symptoms, respiratory rate, oxygen requirements, oxygen saturation, and inflammatory markers. Patients were classified as having a favorable treatment response when they demonstrated clinical improvement with stabilization of vital signs and reduced oxygen requirements, where applicable, without escalation of respiratory support. Patients who developed clinical deterioration, required intensive care admission, mechanical ventilation, or experienced persistent infection despite appropriate treatment were categorized as having an unfavorable response.

Statistical Analysis

Data were analyzed using Statistical Package for Social Sciences (SPSS) version 26.0. Quantitative variables, including age, respiratory rate, laboratory parameters, and duration of hospitalization, were expressed as mean ± standard deviation. Qualitative variables, including gender, comorbidities, radiological findings, and treatment response, were presented as frequencies and percentages. The chi-square test or Fisher's exact test was used to compare categorical variables, while the independent-sample t-test was applied to compare continuous variables between treatment-response groups. Logistic regression analysis was performed to identify independent clinical and radiological predictors of unfavorable treatment response. A p-value of less than 0.05 was considered statistically significant.

Ethical Considerations

Ethical approval was obtained from the relevant institutional review committee before commencement of the study. Written informed consent was obtained from all participants or their legally authorized representatives. Patient confidentiality was maintained throughout the research process, and collected information was used exclusively for research purposes.

The study was conducted at Shaheed Mohtarma Benazir Bhutto Medical University Larkana, from November 2025 to April 2026 and included 80 patients hospitalized with community-acquired pneumonia (CAP). The demographic, clinical, radiological characteristics and treatment outcomes of the enrolled patients were evaluated to identify factors associated with treatment response.

Among the 80 patients, 46 (57.5%) were male and 34 (42.5%) were female. The mean age of the study population was 56.8 ± 15.4 years. Diabetes mellitus was present in 24 (30.0%) patients, whereas hypertension was observed in 29 (36.3%) patients. Regarding presenting clinical features, cough was the most frequently reported symptom, occurring in 72 (90.0%) patients, followed by fever in 68 (85.0%) patients.

Radiological assessment revealed multilobar involvement in 31 (38.8%) patients, while pleural effusion was identified in 14 (17.5%) patients. Based on the assessment of treatment outcomes, 57 (71.3%) patients demonstrated a good response to treatment, whereas 23 (28.7%) patients experienced a poor treatment response. These findings indicated that although most patients responded favorably to treatment, a considerable proportion experienced an unfavorable clinical course.

Table 1: Demographic, Clinical, Radiological Characteristics and Treatment Outcomes of Patients with Community-Acquired Pneumonia (n=80):

Table 1 demonstrated the overall distribution of demographic and clinical characteristics among the study participants. Male patients constituted a slightly higher proportion of the study population than female patients. The mean age of 56.8 ± 15.4 years indicated that CAP affected predominantly middle-aged and older individuals in the enrolled population. Diabetes mellitus and hypertension were the most frequently recorded comorbid conditions. The high prevalence of fever and cough reflected the typical clinical presentation of hospitalized CAP patients. Radiological findings showed that multilobar involvement was more frequent than pleural effusion. Regarding treatment outcomes, approximately seven out of every ten patients achieved a good clinical response, while nearly one-third experienced poor treatment outcomes.

Further analysis was performed to evaluate the association between selected clinical and radiological predictors and treatment response. Patients with multilobar involvement demonstrated a substantially higher frequency of poor treatment response compared with those having single-lobar involvement. Similarly, patients presenting with oxygen saturation below 90% experienced considerably poorer outcomes than those with oxygen saturation of 90% or above.

Table 2: Association of Clinical and Radiological Predictors with Treatment Response Among Patients with Community-Acquired Pneumonia (n=80):

Table 2 demonstrated the relationship between important clinical and radiological parameters and treatment outcomes. Among patients with multilobar involvement, 15 (48.4%) experienced a poor treatment response, compared with only 8 (16.3%) patients with single-lobar involvement. This difference was statistically significant (p=0.002), suggesting that extensive pulmonary involvement was associated with an unfavorable clinical outcome.

Oxygen saturation also demonstrated a strong association with treatment response. Among patients with oxygen saturation below 90%, 13 (72.2%) experienced a poor response, whereas only 5 (27.8%) demonstrated a good response. In comparison, patients with oxygen saturation of 90% or above predominantly achieved favorable outcomes, with 52 (83.9%) showing a good response.

Community-acquired pneumonia (CAP) remained one of the major causes of hospitalization and respiratory complications among adults. The present prospective observational study evaluated the clinical and radiological predictors of treatment response among patients hospitalized with CAP. The findings highlighted the importance of baseline clinical characteristics, laboratory parameters, and radiological abnormalities in determining treatment outcomes. The assessment of these factors provided valuable information regarding disease severity, clinical progression, and response to antimicrobial therapy [11].

The study demonstrated that patients who presented with severe respiratory symptoms, including increased respiratory rate, hypoxemia, tachycardia, and hypotension, generally experienced a less favorable treatment response. These findings suggested that the severity of physiological disturbances at admission played an important role in predicting clinical outcomes. Patients with relatively stable vital signs and preserved oxygen saturation showed better improvement following treatment [12]. Similar observations had been reported in previous studies, which identified respiratory rate, blood pressure, oxygen saturation, and mental status as important indicators of pneumonia severity and prognosis.

Laboratory investigations also contributed significantly to the prediction of treatment response. Elevated total leukocyte count, increased C-reactive protein (CRP), and higher procalcitonin levels were associated with more severe inflammatory responses and delayed clinical improvement. Patients with lower inflammatory marker levels generally demonstrated a more favorable response to antibiotic treatment [13]. Furthermore, abnormalities in renal function and other biochemical parameters were observed more frequently among patients with complicated disease courses. These findings emphasized the importance of comprehensive laboratory evaluation during initial assessment and subsequent monitoring.

Radiological findings also played an essential role in predicting treatment outcomes. Patients with multilobar involvement, bilateral pulmonary infiltrates, pleural effusion, and extensive consolidation experienced comparatively poorer clinical responses than those with localized pulmonary involvement. Extensive radiological abnormalities appeared to reflect greater disease burden and more widespread pulmonary inflammation [14]. In contrast, patients with limited areas of consolidation demonstrated relatively rapid symptomatic improvement and better oxygenation following treatment. These observations indicated that chest radiography and other appropriate imaging investigations provided important prognostic information in hospitalized patients with CAP.

Another important finding was the relationship between comorbid conditions and treatment response. Patients with diabetes mellitus, chronic obstructive pulmonary disease, cardiovascular disorders, and other chronic illnesses experienced relatively prolonged recovery periods. The presence of underlying diseases might have contributed to reduced physiological reserves, impaired immune responses, and increased susceptibility to complications. Older patients also demonstrated a greater likelihood of delayed clinical improvement, which highlighted the importance of considering age and comorbidities during initial risk assessment and treatment planning [15].

The combined assessment of clinical, laboratory, and radiological parameters appeared more informative than evaluating individual predictors independently. Patients presenting with multiple unfavorable characteristics were more likely to experience delayed stabilization, prolonged hospitalization, and complications. These findings supported the use of integrated clinical assessment approaches, including established pneumonia severity scoring systems such as CURB-65 and the Pneumonia Severity Index (PSI), alongside radiological evaluation.

The study had certain limitations. It was conducted at a single tertiary-care hospital, which might have limited the generalizability of the findings to other healthcare settings. The relatively small sample size and limited follow-up period also restricted the assessment of long-term outcomes. Additionally, differences in causative microorganisms, antimicrobial resistance patterns, and treatment regimens might have influenced individual responses.

Despite these limitations, the study provided useful evidence regarding the prognostic importance of clinical and radiological characteristics in hospitalized CAP patients. Early identification of high-risk patients through systematic clinical assessment, laboratory investigations, and radiological evaluation could have supported timely treatment optimization, closer monitoring, and improved patient management.

The study concluded that clinical and radiological parameters played an important role in predicting treatment response among patients hospitalized with community-acquired pneumonia. Early improvement was associated with favorable clinical indicators, including lower disease severity, stable vital signs, adequate oxygen saturation, and absence of significant comorbidities. Conversely, advanced age, underlying medical conditions, hypoxemia, elevated inflammatory markers, and extensive radiological involvement were associated with delayed clinical recovery and an increased risk of complications. Radiological findings, particularly multilobar consolidation and pleural effusion, provided additional information regarding disease severity and treatment outcomes. The combined assessment of clinical characteristics, laboratory investigations, and chest imaging improved the identification of patients at risk of poor treatment response. The findings emphasized the importance of early risk stratification, appropriate antimicrobial therapy, and continuous clinical monitoring. Therefore, an integrated clinical and radiological evaluation was considered essential for optimizing treatment decisions, improving patient outcomes, and reducing hospitalization-related complications.

1. Rahme D, Nakkash Chmaisse H, Salameh P. Clinical outcomes in hospitalized patients with community-acquired pneumonia: A comprehensive analysis of associated factors. Plos one. 2026 Mar 5;21(3):e0344171.
2. Nawaz S. Clinical Profile and Predictors of In-Hospital Mortality Among Patients Admitted with Community-Acquired Pneumonia: Prospective Observational Study. Journal of Pak International Medical College. 2026 Jul 24;4(1):13-9.
3. Pinot J, Delory T, Pétrier M, Auger IA, Whiston M, Issa A, Lenormand M, Partouche H, Gilberg S, Duval X, Le Bel J. Clinical data, chest X-ray or C-reactive protein to initiate antibiotic therapy in outpatients with suspected community-acquired pneumonia: a prospective, randomised, controlled, digital case vignette study. Clinical Microbiology and Infection. 2026 Mar 14.
4. Almaw G. Magnitude of unfavorable treatment outcome and associated factors of severe community-acquired pneumonia admitted to Tibebe Ghion specialized hospital (Doctoral dissertation, Bahir Dar University).
5. Kadhem RH. Clinical Predictors of Non-Response to Initial Antibiotics in Pediatric Community-Acquired Pneumonia: A Risk Score Approach. Thi-Qar Medical Journal. 2026 Jun 4;30(1):19-27.
6. Dash S, Panda SK, Mahapatra DP, Padhy P, Sahoo SM, Panigrahy S. Factors associated with prolonged hospitalization among under-five children with community-acquired pneumonia: A cross-sectional observational study. Student's Journal of Health Research Africa. 2026 Sep 30;7(3):17-.
7. Van Nguyen T, Nguyen VQ, Dinh HC, Ngo TT, Nguyen TD. The impact of nutritional status, comorbidities, and frailty on short-term outcomes in elderly patients with community-acquired pneumonia: A prospective observational study at a tertiary hospital in the South of Vietnam. Heliyon. 2026 Sep 1;12(14).
8. Bonacina C, Ratti E, Galimberti S, Guerrieri A, Ripamonti R, Promi S, Usai P, Raschi S, Piluso M, Parachini L, Melacini C. Helmet Continuous Positive Airway Pressure in Non-COVID Community-Acquired Pneumonia-Related Acute Hypoxemic Respiratory Failure: Clinical Outcomes and Early Prognostic Factors.
9. Muslemin R, Rahman MM, Khuda KM, Iqbal MA, Islam A. Clinical Profile and Outcomes of Patients Hospitalized with Community-Acquired Pneumonia in a Tertiary Care Hospital in Bangladesh. Journal of Netrokona Medical College. 2026 Jun 30;3(1):381-8.
10. Carrillo Sr BA, Robles EA, Franco RA, Yepiz Sr B, Robles Sr EA, Flores RA. C-Reactive Protein as a Predictor of Early Antibiotic Treatment Failure in Hospitalized Patients With Community-Acquired Pneumonia. Cureus. 2026 Jul 1;18(7).
11. Çelik O, Kılıç AF, Kuralay Y, Afşin DE. Exploratory Diagnostic Performance of On-Admission Soluble CD40 Ligand for Distinguishing Acute Pulmonary Embolism from Hospitalization-Requiring Community-Acquired Pneumonia: A Single-Center Observational Study. Diagnostics. 2026 Jun 16;16(12):1877.
12. Masetti M, Zambelli G, Rasmi S, Rossini E, Tramonti SD, Ferrocino M, Fainardi V, Esposito S. Systemic Corticosteroids in Pediatric Community-Acquired Pneumonia: Evidence, Clinical Outcomes, and Phenotype-Based Therapeutic Considerations. Pharmaceuticals. 2026 Aug;19(8):1253.
13. Napiórkowska-Mastalerz M, Wybranowski T, Sikora J, Wszelaki P, Pyskir J, Michalska W, Pilaczyńska-Cemel M, Kruszewski S, Ciastek B. Advanced oxidation protein products and ischemia-modified albumin as prognostic biomarkers of long-term mortality in community-acquired pneumonia: a prospective observational study. Scientific Reports. 2026 Feb 9;16(1):7809.
14. Hossion Z, Hossain Z, Islam F, Yasmin S. Predictive value of neutrophil-to-lymphocyte ratio on hospital outcomes of patients with community-acquired pneumonia. PLoS One. 2026 May 29;21(5):e0348518.
15. Reitala L, Lehto MK, Kekomäki S, Salaspuro M, Dos Anjos E, Silvestre S, Gomes E, Cruzeiro ML, Mejias A, Ramilo O, Pelkonen T. Risk factors associated with disease severity among children hospitalised with community-acquired pneumonia in Angola. Journal of global health. 2026 Apr 30;16:04138.